Literature DB >> 15246625

Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection.

Shigefumi Okamoto1, Shigetada Kawabata, Hideaki Fujitaka, Takashi Uehira, Yoshinobu Okuno, Shigeyuki Hamada.   

Abstract

Intranasal infection with non-lethal influenza A virus (IAV) followed by infection with group A streptococci (GAS) induces invasive, lethal GAS infections, including necrotizing fasciitis, in mice. We demonstrate that subcutaneous immunization of formalin-inactivated IAV vaccine or intranasal immunization of IAV vaccine and cholera toxin protected more than 75% of mice from death by lethal IAV-GAS superinfection. The increased survival rate correlates with increase in IAV neutralizing activity and the levels of serum anti-IAV IgG. Moreover, elimination of IAV from the lungs of vaccinated mice led to depletion of GAS associated with alveolar epithelial cells. These findings suggest that formalin-inactivated IAV vaccine may be useful for prevention of secondary bacterial infections following prior IAV exposure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246625     DOI: 10.1016/j.vaccine.2003.12.024

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  The prospect of vaccination against group A beta-hemolytic streptococci.

Authors:  Karen L Kotloff
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

Review 2.  The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.

Authors:  Amber M Smith; Victor C Huber
Journal:  Viral Immunol       Date:  2017-11-17       Impact factor: 2.257

3.  Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections.

Authors:  Michael S Chaussee; Heather R Sandbulte; Margaret J Schuneman; Frank P Depaula; Leslie A Addengast; Evelyn H Schlenker; Victor C Huber
Journal:  Vaccine       Date:  2011-04-08       Impact factor: 3.641

4.  Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection.

Authors:  Joshua M Klonoski; Heather R Hurtig; Brian A Juber; Margaret J Schuneman; Thomas E Bickett; Joshua M Svendsen; Brandon Burum; Thomas A Penfound; Grigoriy Sereda; James B Dale; Michael S Chaussee; Victor C Huber
Journal:  Vaccine       Date:  2014-07-29       Impact factor: 3.641

Review 5.  Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem.

Authors:  Samson Sy Wong; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2012-07-11       Impact factor: 7.163

6.  Invasive bacterial infections following influenza: a time-series analysis in Montréal, Canada, 1996-2008.

Authors:  R Allard; M Couillard; P Pilon; M Kafka; L Bédard
Journal:  Influenza Other Respir Viruses       Date:  2011-10-10       Impact factor: 4.380

7.  Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection.

Authors:  Andrea L Herrera; Christopher Van Hove; Mary Hanson; James B Dale; Rodney K Tweten; Victor C Huber; Diego Diel; Michael S Chaussee
Journal:  PLoS One       Date:  2020-06-23       Impact factor: 3.240

Review 8.  Noninvasive vaccination against infectious diseases.

Authors:  Zhichao Zheng; Diana Diaz-Arévalo; Hongbing Guan; Mingtao Zeng
Journal:  Hum Vaccin Immunother       Date:  2018-05-17       Impact factor: 3.452

Review 9.  The Association between Invasive Group A Streptococcal Diseases and Viral Respiratory Tract Infections.

Authors:  Andrea L Herrera; Victor C Huber; Michael S Chaussee
Journal:  Front Microbiol       Date:  2016-03-21       Impact factor: 5.640

Review 10.  Molecular and genomic characterization of pathogenic traits of group A Streptococcus pyogenes.

Authors:  Shigeyuki Hamada; Shigetada Kawabata; Ichiro Nakagawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2015       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.